Celgene gets Blue Cross Blue Shield's US antitrust claims over Pomalyst dismissed
MLex Summary: A US judge has granted motions filed by Celgene, Anthony Insogna, and Jerome Zeldis to dismiss antitrust claims filed by Blue Cross Blue Shield accusing them of illegally monopolizing...To view the full article, register now.
Already a subscriber? Click here to view full article